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Abstract
Haspin is an atypical serine/threonine protein kinase essential to mitosis. Unlike other
protein kinases, its kinase domain does not require phosphorylation in order to be
activated and bears very high substrate specificity and selectivity. Few substrates have
been identified so far. Haspin phosphorylation on threonine 3 of Histone H3 from pro-
phase to anaphase participates to centromeric Aurora B localization and ensures proper
kinetochore-microtubule attachment. Haspin is also involved in the maintenance of cen-
tromeric cohesion and the mitotic spindle. Inhibitors have been developed and provided
tools to dissect Haspin function. The kinase is now considered as a potential therapeutic
target against cancer. We discuss here the latest findings on this essential mitotic protein.
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1. Introduction
Protein kinases play an important role in cell cycle regulation. Together with protein phospha-
tases, they regulate the phosphorylation status of thousands of substrates, including proteins
ensuring cell cycle progression. Cell division, that is, mitosis, is a crucial step of the cell cycle
and is essential to genomic stability. Mistakes during this process can cause various develop-
mental diseases and cancers. Its orchestration is highly regulated by various families of protein
kinases, including cyclin-dependent kinases (Cdk), Aurora kinases, polo-like kinases (Plks),
and NimA-related kinases (Neks) whose roles in mitosis are well documented [1, 2]. Haspin is
a serine/threonine kinase discovered in the early 1990s essential to mitosis. Despite recent
progress, regulation of its activity and its biological functions is still poorly understood.
Haspin is involved in chromosome alignment, centromeric cohesion, and spindle stability
making it a potential target against cancer. Latest data from the literature concerning this
protein kinase as well as pharmacological inhibitors are presented.
© 2017 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
2. Discovery
Haspin mRNA was first detected in mouse germ cells in 1994 and named germ cell–specific
gene 2 (GSG2) [3]. The coded protein localizes in the nucleus of germ cells and showed kinase
activity. It was subsequently renamed haploid germ cell–specific nuclear protein kinase
(Haspin) [4]. HaspinmRNA is found in diploid cells of many proliferative tissues such as testis,
thymus, bone marrow, and spleen as well as in many proliferative cell lines [5–7]. Its expres-
sion is comparatively reduced in somatic tissues. In addition, Haspin orthologs were found in
several eukaryotes, such as yeasts, plants, flies, fishes and mammals, and a large group in
Caenorhabditis elegans. Phylogenetic analysis indicates that Haspin proteins form a new family
of eukaryotic proteins kinases (ePK) [5].
3. Haspin, an atypical kinase structure
Human Haspin is a 798 amino acid serine/threonine protein kinase. The N-terminal part (aa
1–469) is the less conserved among species and thought to act as a regulatory domain. The
well-conserved C-terminal part (aa 470–798) corresponds to the catalytic kinase domain [8–10].
To date, Haspin kinase domain was crystallized in the presence of ATP analogs such as
5-iodotubercidin (5-ITu) or in the presence of a specific substrate of the kinase, Histone H3
[8, 10, 11]. Disorganization of the N-terminal domain prevented, so far, crystallization of the
entire protein.
The structure of human Haspin kinase domain (aa 470–798) shows similarity to the kinase
domain from other kinases of the ePK family. As most protein kinases, it includes a small lobe
on the N-terminal side and a large lobe on the C-terminal side. A substrate-binding site and an
ATP binding pocket are found between the two lobes. The catalytic domain of Haspin displays
specific structural features that are not observed in other members of the ePK family.
Compared to canonical protein kinases, Haspin structure revealed several unique and specific
structural features that are highly conserved in several species. These characteristics result
from amino acid insertion, deletion, or changes in the protein sequence of its catalytic domain
in comparison to other ePKs [8, 10]. The structure of most protein kinases is generally very
dynamic, allowing a kinase to transform, by a conformational change, from an inactive to an
active state through phosphorylation or interaction with a partner [12]. On the contrary,
Haspin kinase domain is rigid and fixed in a constitutively active conformational state [8, 10, 11]
(Figure 1A).
This stability is achieved by the combination of different structural elements. Mainly, the
generally mobile glycine rich P-loop is stabilized in Haspin by the insertion of an additional
helix in the upper lobe called either upper lobe helix (ulH) [8] or αC0 helix [10]. This helix
insertion is mostly conserved throughout Haspin orthologs apart from the fission yeast Alk1
and Alk2. Usually, mobile αC helix in the small N-terminal lobe is also stabilized by a number
of hydrophobic contacts. Haspin activation segment is another atypical structural element. In
most kinases, the activation segment has a regulatory purpose, acquiring an active
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conformation upon phosphorylation and allowing substrate binding. Haspin activation seg-
ment is stabilized in a constitutively active conformation [8, 10].
Finally, Haspin bears a very specific substrate-binding site. Knowing that histone H3 tail
(positively charged) is a specific Haspin substrate suggested a negatively charged binding site
as depicted on Figure 1B. Maiolica et al. provided insights into this peculiar substrate-binding
site resolving the crystal structure of Haspin kinase domain bond to the first seven residues of
Histone H3 [11]. The study revealed that three residues of the latter, Ala1, Arg2, and the
phospo-acceptor site Thr3, are deeply anchored in the substrate hydrophilic binding site of
Haspin. These peculiarities create a highly selective substrate-binding site [11].
4. Haspin substrates
Very few substrates of Haspin have been identified and characterized so far. Histone H3 was
the first Haspin substrate to be identified. It is specifically phosphorylated on Thr3 [8, 10, 13].
Figure 1. Haspin kinase domain 3D structure. (A) Insertion elements, αC0 helix, β9 and β90, and β hairpin are indicated.
(B) Representation of Haspin surface electrostatic charges; the negatively charged substrate-binding site is circled.
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This phosphorylation (H3T3ph) was demonstrated both in vitro and in several cell lines by
immunofluorescence, using histone H3 Thr3 phospho-specific antibodies (Figure 5 upper
panel). Haspin depletion by siRNA eliminates H3T3 phosphorylation in mitotic cells, and
ectopic overexpression of Haspin leads to abnormal H3T3 phosphorylation levels in inter-
phase cells confirming that H3T3ph is specific of Haspin activity [7, 14, 15]. H3 is phosphory-
lated on Thr3 through most of mitosis. Kurihara et al. showed that Arabidopsis thaliana Haspin,
AtHAspin, is an H3T3ph kinase. They have further demonstrated that AtHaspin phosphorylates
both Thr3 and Thr11 of Histone H3 in vitro [16, 17]. It is to be noted that Haspin-homologous
proteins in budding yeast, Alk1 and Alk2, have not shown any ability to phosphorylate histones
[18], whereas the fission yeast Haspin-related kinase, Hrk1, has been shown to be the major
H3T3 phosphorylating kinase in this species [19].
Histone macroH2A is an histone variant found enriched on inactive X chromosome of female
mammals [20]. Several studies demonstrated that histone macroH2A functions both as a
positive and a negative regulator of gene transcription. A phosphoproteomic study showed
that inhibition of Haspin by 5-ITu led to a sharp decrease in serine phosphorylation of histone
macroH2A [11]. This phosphorylation was confirmed in vitro and in HEK293 cells, where
overexpression of Haspin caused hyper-phosphorylation of Histone macroH2A on Ser137,
the latter being inhibited by 5-ITu. It has also been reported that the macro domain of Histone
macroH2A controls the levels of Ser10 and Thr3 phosphorylation of histone H3 in human cells
and would be involved in controlling chromatin condensation [21, 22]. The functionality of
Haspin in these mechanisms remains to be confirmed.
CENP-T is a component of the constitutive centromere-associated network (CCAN), which
plays a central role in kinetochore assembly, mitotic progression, and segregation of chromo-
somes [23]. CENP-T has been identified as substrate of Haspin by consensus site prediction
(see below), and its phosphorylation on several sites confirmed by in vitro kinase assay [11].
The Haspin kinase substrate recognition motif has been determined by positional scanning-
oriented peptide library screening (PS-OPLS) as A/V-R-T/S-K-(X-no D/E) with a preference for
threonine residues [11]. Acidic residues have been shown to impair Haspin recognition when
in the surrounding of the phosphorylation site [11].
5. Haspin biological function
5.1. Haspin localization
Haspin is constitutively expressed throughout the cell cycle, unlike other mitotic kinases such
as Aurora B and Plk1, which are degraded at the end of mitosis [13, 24, 25]. So far, the precise
cellular localization of the endogenous protein could not be determined due to lack of
immunofluorescence-specific antibodies to Haspin. However, several overexpression studies
have reported localization of GFP- or Myc-tagged Haspin in different eukaryotic cell lines
(HeLa, U-2 OS, Hek293, COS-7) using time-lapse video microscopy or immunofluorescence
staining techniques or time-lapse video microscopy [4, 13]. All these studies showed that
Haspin localizes in discrete foci and nucleoli in the nucleus during interphase. It is to be noted
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that the N-terminal domain of human Haspin exhibits two potential nuclear localization
signals (NLSs) that are conserved in mice and rats [9]. Localization pattern in mitosis is more
complex (Figure 2).
At the end of G2/onset of prophase, Haspin appears associated with condensed chromosomes
until anaphase B. Myc:Haspin is observed along chromosome arms with a clear concentration
at centromeres [13]. GFP:Haspin was also detected at the centrosomes and mitotic spindle in
prometaphase cells until telophase, where a weak signal is detected in the midbody [13]. Nuclear
and chromosomal localization throughout mitosis of endogenous Haspin:YFP knocked-in have
been recently confirmed by video microscopy [26]. Figure 2 shows the location of Haspin during
the various stages of the cell cycle with emphasis onmitosis (Figure 2). Phosphorylation of histone
H3 on Thr3 was also examined in plants. In most of the species studied, it appears on chromo-
somes at the end of G2 phase and disappears during anaphase [27], in contrast to mammals,
phosphorylation of Thr3 is seen primarily at pericentromeres in prophase and then along chro-
mosome arms during prometaphase [27, 28].
5.2. Specific localization of Haspin during meiosis
GFP:Haspin co-localizes with chromatin and H3T3ph during all meiotic stages [29, 30]. Nota-
bly, H3T3ph levels were increased with overexpression of exogenous Haspin, thus confirming
that Haspin phosphosphorylates H3T3 in oocytes. During metaphase I, Haspin is detected at
the centromeres and along sister chromatids. After metaphase I, GFP:Haspin is also located in
a discrete region of the oocyte’s cortex which is in the immediate vicinity of chromatin and the
spindle [29]. Haspin was also weakly detected as filamentous aggregates on the spindle.
Figure 2. Haspin reported localization along cell cycle in mammal cells.
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At anaphase I/telophase I transition, Haspin is translocated from chromosomes to midbody
[29, 30].
5.3. How is Haspin recruited onto chromosomes?
A yeast two-hybrid screen of cohesin-related proteins on the fission yeast Haspin homolog
Hrk1 identified an interaction with the cohesin-associated protein Pds5 [19]. The interaction
was confirmed in cells using a model in which Pds5:mCherry:LacI was tethered onto a specific
location on a chromosome arm through a LacO/LacI system onto which Hrk1:GFP was shown
to co-localize (Figure 3) [19].
Vertebrates have two version of Pds5 protein, Pds5A and B [31, 32]. Carretero et al. demon-
strated that Pds5B-deficient MEF cells showed a decreased activation of Aurora B and Haspin
at centromeres and an impaired centromeric localization of Aurora B suggesting that Pds5B
may be involved in the recruitment of Haspin on centromeres [33]. The recruitment of Haspin
by Pds5B has been confirmed in human cell lines by Hindriksen et al. [26]. Using a LacO/LacI
system in which Pds5B:RFP:LacI was shown to recruit Haspin:YFP on a LacO repeats inserted
on chromosome 1 of human U-2 OS cells [26].
Two recent studies in Xenopus and yeast showed that SUMOylated DNA topoisomerase IIα C-
terminal domain can bind Haspin and regulate its localization at centromeres [34, 35] (Figure 3).
5.4. Haspin function in mitosis
In vertebrate cell lines, depletion of Haspin by siRNA or treatment with specific inhibitors
leads to a substantial decrease in histone H3 Thr3 phosphorylation during mitosis. Moreover,
Figure 3. Haspin recruitment at centromere. Haspin centromeric localization is dependent on binding to both the
cohesin-associated protein Pds5B and the sumoylated C-terminal domain (CTD) of Topo isomerase II (Topo II).
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cells display many remarkable defects in mitosis. Prometaphase and metaphase duration are
increased due to severe chromosome alignment defects [6, 7, 13] (Figure 4).
Mitosis duration, measured by video microscopy, is increased up to several hours in Haspin-
depleted U-2 OS cells [36]. Mitotic spindles are disorganized with often extra centrosome-like
foci. Impaired centromeric cohesion and premature separation of chromatid have been
reported in Higgins et al. [36].
Haspin has been shown to be the major H3T3 phosphorylating kinase in various organisms [7,
8, 10, 11, 13, 15]. Phosphorylation on H3T3 appears first at the end of G2 phase of the cell cycle
and disappears during anaphase B (Figure 5 upper panel). H3T3ph is well marked in prophase.
At this stage, it is nuclear and more precisely located on condensing chromosome arms.
During prometaphase, phosphorylation is concentrated on centromeres in a region delimited
by centromeric CENP-A (inner centromere). The phosphorylation decreases rapidly at ana-
phase and can still be observed on telomeres present in the vicinity of Aurora B activity area on
the midzone. It is no longer detected on chromosomes, when cells are in late telophase
(Figure 5 upper panel) [6, 7, 13, 14].
The H3T3ph-dephosphorylating enzyme has been shown to be the PP1γ phosphatase specifi-
cally targeted to anaphase chromosomes by its regulatory subunit Repo-Man [37, 38]. Further
studies showed that Repo-Man targeting to chromosomes is negatively regulated through
Aurora B phosphorylation explaining the persistent H3T3ph signal observed on telomeres at
anaphase [37].
Histone H3 phosphorylated on threonine 3 is directly recognized by the conserved BIR
domain of Survivin, a member of the chromosomal passenger complex (CPC) [14, 19, 39], thus
Figure 4. Haspin depletion by siRNA. Immunofluorescence images of Haspin and control siRNA on U2 OS cells. Haspin-
depleted cells show chromosome alignment defects, impaired spindles, and ectopic spindle poles.
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anchoring the CPC at centromeres. The CPC is a complex of four subunits, Survivin, Borealin,
INCENP, and the Aurora B kinase. Aurora B is an essential kinase, which regulates mitotic
progression, including spindle assembly checkpoint, condensation, and chromosomal bi-
orientation and cytokinesis [40–42]. Additionally, Aurora B phosphorylates Haspin N-terminus
Figure 5. Haspin activity on Thr3 of histone H3. Upper panel, localization of Haspin activity on Thr3 of histone H3 along
the cell cycle in mammal cells. Lower panel, schematic representation of Haspin-aurora B positive feedback loop at
centromere.
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on several sites allowing its over-activation and creating a positive feedback loop triggering the
accumulation of CPC at the centromeres [14] (Figure 4 lower panel).
The recruitment of CPC at centromere is not only dependent on H3T3ph by Haspin. A second
parallel pathway involving histone H2A phosphorylation on Thr120 by Bub1 creates a binding
site for Shugoshin, a protein involved in the protection of centromeric cohesion. Shugoshin
binds directly to Survivin in yeast and to Borealin CPC member in human in a comparable
manner [14, 43, 44].
Therefore, one of the major functions of Haspin is, together with Bub1 kinase, to bring the CPC
at centromeres (Figure 6).
Haspin has been shown to be involved in chromosomal cohesion. Defects in chromosome
alignment in Haspin-depleted cells are probably due, at least in part, to a premature loss of
sister chromatid cohesion [6].
A recent study has demonstrated that, during mitosis, Haspin binds to the cohesin-associated
protein Pds5B [45]. During prophase and prometaphase, sister chromatids resolution occurs
through cohesion release upon binding of Wapl protein to Pds5B. Zhou et al. showed that
Haspin interaction with Pds5B inhibits Wapl binding, protecting from premature centromeric
cohesion loss [45].
5.5. Regulation of Haspin activity
The N-terminal domain of Haspin appears to be involved in both the intracellular localization
of the protein and in the regulation of its kinase domain activity. Indeed, it has been shown
that presence of the N-terminal domain changes the phosphorylation kinetics of Histone H3
substrate peptides, when compared to the catalytic C-terminal part alone, increasing the Km
for ATP and lowering the affinity for Histone H3 [10]. Thus, the N-terminal domain has the
potential to modulate the activity of the enzyme [10].
Figure 6. Haspin, together with Bub1, is required for anchoring the CPC at centromere. Svn: Survivin; INC: INCENP;
Bor: Borealin; Aur B: Aurora B; Sgo: Shugoshin; CPC: Chromosomal passenger complex.
The Mitotic Protein Kinase Haspin and Its Inhibitors
http://dx.doi.org/10.5772/intechopen.70732
39
Haspin is expressed throughout the cell cycle [13, 46]. However, it is highly phosphorylated
during mitosis [13]. Phosphoproteomic studies showed that these phosphorylations are on the
N-terminal domain of the protein, where phosphorylation consensus sites for Cdk1, Plk1, and
Aurora B are present [45–47]. Phosphoryation events on the N-terminal domain at the onset of
mitosis trigger conformational changes and influence Haspin kinetics parameters (see above).
Haspin phosphorylation by Cdk1/cyclin B starts on T128 of human Haspin (T206 in Xenopus
laevis) [47, 48]. Gheniou et al. showed that Xenopus Haspin auto-inhibits itself during inter-
phase through a conserved basic site in its N-terminus part close to its kinase domain [47]. This
auto-inhibition is released through Cdk1 phosphorylation of Haspin N-terminus followed by
the recruitment of Plk1 on the Cdk1 phospho-site and its activation. Activated Plk1 phosphor-
ylates several sites on Haspin N-terminus releasing its activity in a timely manner at the
beginning of mitosis triggering H3T3 phosphorylation and CPC recruitment at centromeres
[47, 48]. Furthermore, Wang et al. showed that Aurora B further phosphorylates Haspin N-
terminus enhancing its ability to generate H3T3 phospho-sites for Survivin/CPC binding [49]
(Figure 5 lower panel). Another recent study showed that Aurora A also phosphorylates
Haspin N-terminus triggering the Aurora B/Haspin feedback loop [50].
Several reports showed that H3T3 phosphorylation by Haspin is regulated by modifications
on adjacent residues Arg2 and Lys4. As such, methylation on Arg2 as well as acetylation and
methylation on Lys4 strongly decreased the ability of Haspin to phosphorylate Thr3 [8, 51].
These results imply a likely epigenetic regulation of Haspin and Aurora B activities.
5.6. Haspin function in meiosis
Studies of Haspin function during meiosis were performed on mouse oocytes using small
molecule inhibitors and overexpression. Similarly to mitosis, Haspin phosphorylates Thr3 of
histone H3 [29, 46]. This phosphorylation is necessary for accurate meiosis including chroma-
tin condensation and formation of the microtubule assembly checkpoint, ensuring faithful
segregation of chromosomes during meiosis I [29, 46]. Furthermore, Haspin phosphorylation
on H3T3 has been shown to be required for Aurora C kinase proper localization during
meiosis [29, 46]. During meiosis I, in contrast to mitosis, where Haspin is involved in CPC
targeting to centromeres, Haspin regulates Aurora C localization to the inter-chromatid axis
[29, 30]. Inhibition of Haspin by 5-ITu showed a failure to organize microtubules and an
increase in microtubule organizing centers (MTOCs) as well as an impaired localization of
Aurora C at this location. These results suggested a new role for Haspin in the regulation of
MTOCs clustering during meiosis and Aurora C localization at MTOC supporting the idea of
different functions of Haspin in meiosis compared to mitosis [30].
6. Haspin as a therapeutic target
Mitotic protein kinases are considered as targets of choice for drugs developed by the pharma-
ceutical industry [52]. Because of its role in controlling the activity of Aurora B and in
maintaining the cohesion of centromeres and spindle poles, Haspin has become a relevant
target for cancer therapy and is considered as an emerging anti-mitotic drug target [53, 54].
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The fact that Haspin is an atypical ePK with a divergent structure may lead to the development
of inhibitors with fewer side effects [4, 5]. Haspin inhibitor CHR6494 described by Huertas
et al. showed antitumor activity in a xenograph mouse model [53]. Haspin is also
overexpressed in some malignant tumors such as Burkitt’s lymphoma and chronic lympho-
cytic leukemias [55, 56]. In addition, Haspin was identified in a whole kinome siRNA screen,
together with Plk1, as one of the top hit kinases, whose depletion decreased both cell viability
and estrogen receptor transcriptional activity in MCF7 breast cancer cells [57]. Thus, Haspin
may represent a new anti-cancer therapeutic target.
7. Haspin inhibitors
There are only few reports on conception of Haspin inhibitors (Figure 7). Most publications
reported the evaluation of molecules on a kinase panel, including Haspin kinase.
One of the first molecules used in researches on Haspin was the well-known 5-ITu for its
potent inhibition of adenosine kinase. This nucleotide-like molecule inhibits strongly Haspin
with IC50 ranged between 5 and 9 nM. Initially, 5-ITu was mostly used to get a better under-
standing of Haspin structure and could also be considered as a tool for biological studies. 5-ITu
was recently used to assess biological function of Haspin on the cell cycle, especially during
mitosis and meiosis (see above). Cuny et al. described the screening, synthesis, and biological
Figure 7. Haspin inhibitors described in the literature.
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evaluation of two compounds with interesting activities on Haspin [58]. The study was mostly
devoted to target Dyrk2 and Haspin kinases for their role on proliferating cells. After a
screening of 140,000 species, an acridine analog demonstrated an interesting profile, and
authors isolated LDN-192960, which showed remarkable inhibition of Haspin kinase
(IC50 = 10 nM). In 2012, the same team synthesized a library of harmine derivative with the
same amino-alkyl chain. The newly generated LDN-211898 is described as an inhibitor active
at submicromolar concentration against Haspin in an in vitro assay (100 nM). Recently,
Novartis realized a large screen using Melk inhibitors and found that the compound Melk8a
had the best inhibition potency against Haspin (IC50 = 190 nM). However, this compound also
showed activities below 1 μM of other kinases including Gsk3, Cdk2, Akt1, Flt3 and was
therefore not selective. This year, Pastor Fernández et al. described the synthesis of tricyclic
compounds as new kinases inhibitors [59]. Mostly, the patented molecules have strong activi-
ties against Cdk8, Cdk19, and Haspin, as shown for inhibitor L1 (IC50 = 9 nM). A similar
approach was used by Chen et al., who first described SGI-1776 as a Pim1 inhibitor [60]. In
vitro evaluation of this compound on a panel of kinases gave an IC50 of 34 nM on Haspin. This
study was the starting point for screening of other imidazopyridazine as strong Haspin
inhibitors. In 2012, Huertas et al. described in vitro, in cells, and in vivo activities of a little
imidazoipyridazine named CHR6494 [53]. This molecule seems to be an ATP competitive drug
commonly denominated as a type I kinase inhibitor showing a strong inhibition of Haspin
with a remarkable IC50 of 2 nM.
Kestav et al. developed another original type of inhibitors. They synthetized conjugates bear-
ing an aromatic fragment fused to a peptide mimicking the N-terminus of histone H3. Their
best compounds showed a Kd of 0.42 nM on Haspin kinase with a good selectivity index [61].
8. Conclusion
Haspin protein kinase was discovered two decades ago. Despite several years of research, the
only well characterized substrate, with a specific function, is Histone H3 Thr3. This atypical
kinase and its essential role in the regulation of CPC activity in space and time along mitosis,
through Thr3 phosphorylation of Histone H3, has become a very attractive subject. The latest
findings reviewed here show that there is still much to discover about the function and
regulation of this kinase. Although Haspin inhibitors have shown to be very useful tools in
dissecting the kinase function in diverse biological mechanisms within multiple organisms, we
expect to see their development toward therapeutic drugs in the coming years.
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